Second Coronavirus Vaccine Unveiled in Iran
TEHRAN (FNA)- Iran’s Razi Vaccine and Serum Research Institute (RVSRI) unveiled the second home-grown vaccine and its first injectable-inhaled vaccine of COVID-19 recombinant protein, "Razi Cov-Pars", on Sunday.
Razi Institute unveiled its first vaccine for coronavirus on Sunday in the presence of Agriculture Minister Kazzem Khavazi and Health Minister Saeed Namaki.
"The vaccine is made by a special team of Iranian doctors, pharmacists, veterinarians, and chemists at the Razi Institute, which fully complies with the instructions of the World Health Organization (WHO) and the Food and Drug Administration (FDA)," Khavazi said.
"This vaccine has been produced under the direct supervision of the Iranian Ministry of Health and in full cooperation with the Medical Equipment Department," he said, adding, "We hope to pass the 1st and 2nd human trials successfully."
Iran unveiled its first homemade vaccine on 29 of December 2020.
"We have been producing vaccines in the country for a hundred years. Pasteur Institute of Iran was set up in 1920 and Razi Vaccine and Serum Research Institute was founded in 1924," Namaki said on the sidelines of the unveiling ceremony of the vaccine and the first phase of the clinical trial of Iranian-made COVID-19 vaccine on 56 volunteers.
"We were the first producer of vaccines in Asia and we have sent vaccines to many countries in the world," he added.
"Due to our record in vaccine production, we are trying to offer new vaccines with the help of the Science and Technology Vice-Presidency, knowledge-based companies, the Pasteur Institute of Iran, the Razi Vaccine and Serum Research Institute and the private sector," the minister noted.
"We have developed various platforms for coronavirus, including the vaccine, the first human phase of which was performed today," Namaki said, and added, "Another platform is also underway at Razi Institute, and its animal tests are underway and will soon receive a human testing license."
"We hope that we will soon see the start of the second human trial phase of this national vaccine and then the third phase to be followed by its mass production," he continued.